Labcorp Holdings (LH)
NYSE:LH
LH Stock Chart & Stats
$266.73
-$1.45(-0.62%)
At close: 4:00 PM EST
$266.73
-$1.45(-0.62%)
Day’s Range― - ―
52-Week Range$209.38 - $293.72
Previous CloseN/A
Volume103.18K
Average Volume (3M)532.32K
Market Cap
$21.98B
Enterprise Value$28.79B
Total Cash (Recent Filing)$532.30M
Total Debt (Recent Filing)$7.21B
Price to Earnings (P/E)23.8
Beta0.33
Next Earnings
Apr 30, 2026EPS Estimate
4.12Next Dividend Ex-DateN/A
Dividend Yield1.14%
Share Statistics
EPS (TTM)4.07
Shares Outstanding82,400,000
10 Day Avg. Volume514,496
30 Day Avg. Volume532,317
Financial Highlights & Ratios
PEG Ratio1.28
Price to Book (P/B)2.42
Price to Sales (P/S)1.50
P/FCF Ratio17.31
Enterprise Value/Market Cap1.31
Enterprise Value/Revenue2.06
Enterprise Value/Gross Profit7.31
Enterprise Value/Ebitda14.30
Forecast
1Y Price Target
$308.63Price Target Upside15.71% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)17.86
Revenue Forecast (FY)$14.67B
Bulls Say, Bears Say
Bulls Say
Guidance Supporting FundamentalsAnalyst notes company guidance exceeded expectations for revenue and earnings, indicating improving fundamentals and reducing downside risk for future results.
Margin Improvement ProgramManagement's streamlining program in the esoteric diagnostics unit aims to remove lower-margin business and raise operating margins, which could materially improve laboratory profitability.
Mergers And Acquisitions PipelineAnalyst highlights a solid mergers and acquisitions pipeline that could add higher-margin services and accelerate growth beyond organic trends.
Bears Say
Concentration Risk In Diagnostic ReferralsSofter diagnostic volumes driven by reduced referrals from a consumer genetics client expose concentration risk and potential volatility in future demand.
Esoteric Diagnostics DisruptionContinued disruption in the esoteric diagnostics unit is weighing on segment performance and pressuring the stock through weaker operating results.
Revenue ShortfallReported revenue missed expectations, creating concern about near-term top-line momentum and investor confidence.
Labcorp Holdings News
LH FAQ
What was Labcorp Holdings’s price range in the past 12 months?
Labcorp Holdings lowest stock price was $209.38 and its highest was $293.72 in the past 12 months.
What is Labcorp Holdings’s market cap?
Labcorp Holdings’s market cap is $21.98B.
When is Labcorp Holdings’s upcoming earnings report date?
Labcorp Holdings’s upcoming earnings report date is Apr 30, 2026 which is in 14 days.
How were Labcorp Holdings’s earnings last quarter?
Labcorp Holdings released its earnings results on Feb 17, 2026. The company reported $4.07 earnings per share for the quarter, beating the consensus estimate of $3.946 by $0.124.
Is Labcorp Holdings overvalued?
According to Wall Street analysts Labcorp Holdings’s price is currently Undervalued.
Does Labcorp Holdings pay dividends?
Labcorp Holdings pays a Quarterly dividend of $0.72 which represents an annual dividend yield of 1.14%. See more information on Labcorp Holdings dividends here
What is Labcorp Holdings’s EPS estimate?
Labcorp Holdings’s EPS estimate is 4.12.
How many shares outstanding does Labcorp Holdings have?
Labcorp Holdings has 82,400,000 shares outstanding.
What happened to Labcorp Holdings’s price movement after its last earnings report?
Labcorp Holdings reported an EPS of $4.07 in its last earnings report, beating expectations of $3.946. Following the earnings report the stock price went down -2.109%.
Which hedge fund is a major shareholder of Labcorp Holdings?
Currently, no hedge funds are holding shares in LH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Labcorp Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$308.63 (15.71% Upside)
$308.63 (15.71% Upside)
Blogger Sentiment
Bullish
LH Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 300.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 0.2%
Last 30 Days ▲ 3.0%
Last 30 Days ▲ 3.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
19.17%
12-Months-Change
Fundamentals
Return on Equity
10.28%
Trailing 12-Months
Asset Growth
0.07%
Trailing 12-Months
Company Description
Labcorp Holdings
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
LH Company Deck
LH Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call portrays a fundamentally strong and growing business: solid full-year revenue and EPS growth, margin expansion, robust central lab backlog and book-to-bill, continued product launches and AI/automation investments, plus a constructive 2026 guidance. Offsetting risks include a meaningful decline in early development revenue (being actively addressed via streamlining), a one-off Q4 volume hit from a large consumer-genetics client and weather, higher near-term capital spending for a new central lab facility, and ongoing reimbursement/regulatory uncertainty (PAMA). On balance, the positives (organic growth, margin expansion, strong backlog/book-to-bill, innovation and disciplined capital allocation) outweigh the headwinds, though management expects some transitional impacts in ED and incremental capex this year.View all LH earnings summariesLH Revenue Breakdown
77.96% Dx
22.21% BLS
-0.16% Intercompany eliminations
LH Stock 12 Month Forecast
Average Price Target
$308.63
▲(15.71% Upside)
Technical Analysis
Ownership Overview
0.33% Insiders
31.02% Mutual Funds
20.18% Other Institutional Investors
23.10% Public Companies and Individual Investors